Download Chlamydia trachomatis IgG and IgA

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Microbicides for sexually transmitted diseases wikipedia , lookup

Brucellosis wikipedia , lookup

Herpes simplex wikipedia , lookup

West Nile fever wikipedia , lookup

Chagas disease wikipedia , lookup

Leptospirosis wikipedia , lookup

Marburg virus disease wikipedia , lookup

Anaerobic infection wikipedia , lookup

Trichinosis wikipedia , lookup

Sarcocystis wikipedia , lookup

Surround optical-fiber immunoassay wikipedia , lookup

African trypanosomiasis wikipedia , lookup

Neisseria meningitidis wikipedia , lookup

Diagnosis of HIV/AIDS wikipedia , lookup

Toxoplasmosis wikipedia , lookup

Hepatitis C wikipedia , lookup

Chickenpox wikipedia , lookup

Dirofilaria immitis wikipedia , lookup

Middle East respiratory syndrome wikipedia , lookup

Coccidioidomycosis wikipedia , lookup

Schistosomiasis wikipedia , lookup

Oesophagostomum wikipedia , lookup

Neonatal infection wikipedia , lookup

Sexually transmitted infection wikipedia , lookup

Human cytomegalovirus wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Hepatitis B wikipedia , lookup

Transcript
Infectious Disease
Chlamydia
trachomatis IgG and IgA
The first fully automated solution
for Chlamydia trachomatis antibody detection
FOR OUTSIDE THE US AND CANADA ONLY
Infectious Disease
Chlamydia trachomatis IgG and IgA
The unique technological advantages of the LIAISON® systems, the quality of the reagents and
antigen selection have been combined to create a new approach to the Chlamydia trachomatis
diagnosis.
Chlamydia trachomatis is one the most common cause of sexually
transmitted diseases worldwide.
Chlamydial infection is asymptomatic in most women and many
men: left untreated, it leads to sequelae that place heavy medical,
psychosocial, and economic burdens on women, men, infants and
the healthcare system.
As infections are either asymptomatic, laboratory techniques are the
sole means of diagnosing acute infections. DiaSorin LIAISON® serology
line has been developed to influence patient management and to
make quick and rapid diagnosis of Chlamydia trachomatis infection.
The detection of specific IgA antibodies is indicative of active
Chlamydial infection and has been shown to be an important
marker because of the shorter lifetime of IgA antibodies which
persist only as long as antigenic stimulation exists.
IgA antibody detection is, moreover, suitable for post-therapy
follow-up.
IgG antibody detection is a marker for a Chlamydia-positive immuneresponse, either for current, chronic or past infections.
For a reliable interpretation of results both IgG and IgA antibodies
must be tested.
Indirect assays format
Interpretation of results
4 biotynilated peptides
IgG
IgG results
IgA results
Interpretation of results
Negative
Negative
No evidence of infection.
Positive
Negative
May indicate past infection.
Positive
Positive
May indicate acute
or chronic infection.
Negative
Positive
May indicate acute
or reactivation.
IgG anti-human
IgG conjugate
4 biotynilated peptides
IgA
IgG anti-human
IgA conjugate
Main Features of C. trachomatis assays
Flexibility enables quick and accurate results
•
•
•
•
•
•
•
•
•
•
Number of tests: 100
Antigen: 4 biotynilated peptides
Label: Isoluminol derivative
Method: CLIA
Assay format: semi-quantitative IgG assay, qualitative
IgA assay
Sample type: Serum/Plasma
High throughput
Reagent stability on board: 8 weeks
Two-point calibration for IgA and IgG assays stable
for 8 weeks
Sample volume: 20 μL
LIAISON® Chlamydia trachomatis IgG (code 310570)
LIAISON® Chlamydia trachomatis IgA (code 310580)
AVAILABLE ON
LIAISON® control Chlamydia trachomatis IgG (code 310571)
LIAISON® control Chlamydia trachomatis IgA (code 310581)
SYSTEMS
M0870004284/B 07/15
Ordering information
Product availability subject to required regulatory approval
Diasorin Ireland Ltd.
Unit 13/14 Holly Avenue
Stillorgan Industrial Park
Blackrock Co. Dublin Ireland
www.diasorin.com
[email protected]